Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	vocalization behavior	NLGN4X SHANK1 NLGN4Y SHANK3 MYH14	9.02e-06	24	251	5	GO:0071625
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CADM3 CDH23 CADM2 PTPRG PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	1.92e-05	187	251	11	GO:0007156
GeneOntologyCellularComponent	glutamatergic synapse	ERBB4 RPS6KB1 DGKQ SYNPO FZD9 GRID2IP NLGN4X ACAN CPT1C NAE1 SCN2A CLTA AP3D1 SHANK1 PRUNE2 AMPH NLGN4Y DBNL SHANK3 ARPC2 GRIP1 SLC6A7 RABEP1 LPA PRKAR1B SCRIB CDH8	1.92e-06	817	250	27	GO:0098978
GeneOntologyCellularComponent	lipoprotein particle	APOBR APOL2 APOB APOL1 LPA	1.74e-04	44	250	5	GO:1990777
GeneOntologyCellularComponent	plasma lipoprotein particle	APOBR APOL2 APOB APOL1 LPA	1.74e-04	44	250	5	GO:0034358
GeneOntologyCellularComponent	triglyceride-rich plasma lipoprotein particle	APOBR APOL2 APOB APOL1	1.76e-04	24	250	4	GO:0034385
GeneOntologyCellularComponent	very-low-density lipoprotein particle	APOBR APOL2 APOB APOL1	1.76e-04	24	250	4	GO:0034361
GeneOntologyCellularComponent	collagen-containing extracellular matrix	THSD4 SSPOP FREM1 SLIT2 MFAP4 ACAN IMPG2 ADAMTSL1 ABI3BP MMP28 LAMA3 FREM3 SERPINH1 THBS1 LPA VCAN CSPG4	2.34e-04	530	250	17	GO:0062023
GeneOntologyCellularComponent	protein-lipid complex	APOBR APOL2 APOB APOL1 LPA	2.39e-04	47	250	5	GO:0032994
GeneOntologyCellularComponent	synaptic membrane	CADM3 ERBB4 GRID2IP NLGN4X SCN1A SCN2A CLTA HTR3D GRIN3B SHANK1 NLGN4Y DBNL SHANK3 GRIP1 SLC6A7 CNTNAP4 SCRIB CDH8	2.45e-04	583	250	18	GO:0097060
GeneOntologyCellularComponent	extracellular matrix	THSD4 SSPOP SVEP1 FREM1 SLIT2 MFAP4 ACAN MMP11 IMPG2 ADAMTSL1 ABI3BP MMP28 LAMA3 FREM3 SERPINH1 THBS1 LPA VCAN CSPG4	3.67e-04	656	250	19	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	THSD4 SSPOP SVEP1 FREM1 SLIT2 MFAP4 ACAN MMP11 IMPG2 ADAMTSL1 ABI3BP MMP28 LAMA3 FREM3 SERPINH1 THBS1 LPA VCAN CSPG4	3.81e-04	658	250	19	GO:0030312
GeneOntologyCellularComponent	catenin complex	CDH23 CDH24 CDH8 CDH17	5.52e-04	32	250	4	GO:0016342
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4X NLGN4Y	8.41e-04	4	250	2	GO:0098983
GeneOntologyCellularComponent	voltage-gated sodium channel complex	SCN1A SCN2A SCN4A	1.02e-03	17	250	3	GO:0001518
GeneOntologyCellularComponent	presynapse	CADM3 ERBB4 DGKQ BCL2L1 GIT2 NLGN4X SCN1A SCN2A CLTA GRIN3B AP3D1 PRUNE2 AMPH NLGN4Y DBNL ARPC2 GRIP1 SLC6A7 RABEP1 CNTNAP4 SCRIB CDH8	1.02e-03	886	250	22	GO:0098793
GeneOntologyCellularComponent	postsynaptic density	ERBB4 SYNPO GRID2IP NLGN4X GRIN3B NCK2 SHANK1 ABI3BP NLGN4Y DBNL SH2D5 SHANK3 GRIP1 SCRIB	1.13e-03	451	250	14	GO:0014069
Domain	Cadherin	CDH23 FREM1 PCDH19 FAT4 PCDHB2 FREM3 CDH24 PCDH7 CDH8 CDH17	3.42e-06	118	244	10	IPR002126
Domain	-	ADGRV1 SVEP1 SLIT2 FAT4 LAMA3 THBS1 CSPG4 CNTNAP4	3.46e-05	95	244	8	2.60.120.200
Domain	Cadherin_CS	CDH23 PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	9.24e-05	109	244	8	IPR020894
Domain	Laminin_G	SLIT2 FAT4 LAMA3 THBS1 CSPG4 CNTNAP4	1.07e-04	58	244	6	IPR001791
Domain	CADHERIN_1	CDH23 PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	1.19e-04	113	244	8	PS00232
Domain	Cadherin	CDH23 PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	1.19e-04	113	244	8	PF00028
Domain	-	CDH23 PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	1.27e-04	114	244	8	2.60.40.60
Domain	CADHERIN_2	CDH23 PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	1.27e-04	114	244	8	PS50268
Domain	LAM_G_DOMAIN	SLIT2 FAT4 LAMA3 CSPG4 CNTNAP4	1.29e-04	38	244	5	PS50025
Domain	CA	CDH23 PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	1.34e-04	115	244	8	SM00112
Domain	Cadherin-like	CDH23 PCDH19 FAT4 PCDHB2 CDH24 PCDH7 CDH8 CDH17	1.43e-04	116	244	8	IPR015919
Domain	Laminin_G_2	SLIT2 FAT4 LAMA3 CSPG4 CNTNAP4	1.65e-04	40	244	5	PF02210
Domain	NLGN4	NLGN4X NLGN4Y	1.70e-04	2	244	2	IPR030025
Domain	Calx_beta	ADGRV1 FREM1 FREM3	1.75e-04	9	244	3	IPR003644
Domain	Calx-beta	ADGRV1 FREM1 FREM3	1.75e-04	9	244	3	PF03160
Domain	Na_channel_asu	SCN1A SCN2A SCN4A	2.47e-04	10	244	3	IPR001696
Domain	Na_trans_assoc	SCN1A SCN2A SCN4A	2.47e-04	10	244	3	IPR010526
Domain	Na_trans_assoc	SCN1A SCN2A SCN4A	2.47e-04	10	244	3	PF06512
Domain	LamG	SLIT2 FAT4 LAMA3 CSPG4 CNTNAP4	2.62e-04	44	244	5	SM00282
Domain	SAPS	PPP6R1 PPP6R2	5.06e-04	3	244	2	IPR007587
Domain	SAPS	PPP6R1 PPP6R2	5.06e-04	3	244	2	PF04499
Domain	PDZ	GRID2IP SHANK1 LNX2 SHANK3 GRIP1 SCRIB MAST3 AHNAK2	5.39e-04	141	244	8	PF00595
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	OBSCN KDM3B DGKQ REXO1 HIRA JUND EHBP1L1 MDN1 TULP4 CD2BP2 SURF6 MTMR3 CPSF1 COBL PLA2G6 ULK1 KIFC3 HERC2 MCF2L AP3D1 NCK2 PLXNA3 OFD1 NSD1 PPP6R1 PRKRIP1 ATP13A2 SBNO2 KMT2D SND1 PLA2G4B CSPG4 PCNX1 PKN1 SNAPC4 AHNAK2	7.55e-14	1105	255	36	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GAPVD1 PSMA5 KDM3B REXO1 USP19 JUND MDN1 RBM14 CPSF1 DHX29 PRRC2A DEAF1 PHRF1 ATF2 ZNF768 KMT2D MDC1 SAFB2 PKN1 SCRIB SNAPC4 PCDH7 ZMYM4 CDH17	3.69e-09	774	255	24	15302935
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	MAGEA10 SYNPO ACAN CLNS1A TAF7L CPSF1 PLA2G6 HERC2 EIF2AK3 SHANK1 FAT4 RIOK1 ATG2B APOB CERT1 THBS1 P4HB MDC1 ZMYM4	1.03e-08	513	255	19	25798074
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RPS6KB1 OBSCN SYNPO ADGRV1 SSPOP TTC19 TASOR2 CEP170 ASAP2 PTPRG TULP4 COBL PLA2G6 ATP11A MCF2L NCK2 PRUNE2 NLGN4Y LAMA3 VPS54 MSH5 PRKRIP1 CERT1 SBNO2 NACC2 MYH14 CLMN PLEKHG3 RABEP1 PRKAR1B PKN1 VPS13B ZMYM4	1.72e-08	1489	255	33	28611215
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TPRN BLMH PTPRG SSH3 CD2BP2 CLNS1A CLTA MTMR3 GNL2 CPSF1 PHLPP1 NHS HERC2 TRIM36 PRRC2A NCK2 DPYSL3 OFD1 PPP6R1 KMT2D P4HB INTS4 SCRIB CDC25A RPA1 PPP6R2 PCDH7	1.90e-08	1049	255	27	27880917
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GAPVD1 MRPL12 ZC3H15 NACA KDM3B CEP170 SURF6 GNL2 DHX29 PRRC2A AP3D1 DPYSL3 RIOK1 ZBTB33 DBNL ATG2B PPP6R1 SND1 CLMN RABEP1 SAFB2 SCRIB RPA1 PPP6R2 AHNAK2	3.12e-08	934	255	25	33916271
Pubmed	Overview of inactivating mutations in the protein-coding genome of the mouse reference strain C57BL/6J.	MKRN4P ACAN HERC2 APOL2 ITGA10 APOL1 RABEP1	1.58e-07	55	255	7	29997285
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	REXO1 USP20 CEP170 ASAP2 TULP4 CD2BP2 ATP11A PRUNE2 SH3TC2 GPAM SHANK3 PLEKHG3 N4BP2 SAFB2 CNTNAP4 PPP6R2 MAST3	1.73e-07	493	255	17	15368895
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GAPVD1 PSMA5 NACA BLMH CEP170 SLIT2 MDN1 CLTA RBM14 GNL2 CPSF1 NOL7 HERC2 OFD1 SERPINH1 ARPC2 SND1 MYH14 P4HB PLEKHG3 MDC1 SAFB2 SCRIB RPA1 NNT	1.79e-07	1024	255	25	24711643
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ZSWIM8 SYNPO CCDC88B TASOR2 SLIT2 KIAA1549L CLTA COBL RIC3 SHANK1 DEAF1 DBNL SHANK3 LAP3 ARPC2 GRIP1 SND1 SAFB2	2.10e-07	560	255	18	21653829
Pubmed	HERC2-USP20 axis regulates DNA damage checkpoint through Claspin.	USP20 HERC2 CLSPN	3.90e-07	3	255	3	25355518
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZSWIM8 GAPVD1 TASOR2 CEP170 MDN1 SURF6 GNL2 CPSF1 HERC2 PRRC2A PHRF1 NSD1 SERPINH1 SND1 MYH14 P4HB MDC1 MPHOSPH10 NNT	4.36e-07	653	255	19	22586326
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GAPVD1 ERBB4 KDM3B MEX3C CEP170 MDN1 RBM14 COBL NHS DOP1B DPYSL3 OFD1 DBNL SERPINH1 GRIP1 CLMN PLEKHG3 RABEP1 N4BP2 SCRIB PCDH7 AHNAK2	4.76e-07	861	255	22	36931259
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	FREM1 MFAP4 ADAMTSL1 ABI3BP LAMA3 SERPINH1 THBS1 LPA VCAN CSPG4	4.85e-07	167	255	10	22159717
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	THSD4 OBSCN SPTBN5 SSH3 DOP1B PLXNA3 THBS1 SND1 CLMN PKN1 PCDH7	5.96e-07	214	255	11	22199357
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	NLGN4X SHANK1 NLGN4Y SHANK3	8.95e-07	11	255	4	26403076
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	ZC3H15 RPS6KB1 PSMA5 BCL2L1 TTC19 BLMH CPNE6 CLTA NOL7 MCF2L NCK2 PLXNA3 AMPH DEAF1 RETREG2 RBBP5 PPP6R1 SERPINH1 ATP13A2 ZNF768 LAP3 PKN1 SNAPC4 CDC25A RPA1	9.86e-07	1124	255	25	21900206
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	GAPVD1 PSMA5 NAP1L5 NACA KDM3B USP19 BLMH EHBP1L1 GSPT2 NAE1 CLNS1A TOMM34 AP3D1 PRUNE2 DPYSL3 DBNL CERT1 SERPINH1 PAIP1 LAP3 ARPC2 SND1 MYH14 P4HB RABEP1 PRKAR1B ZFYVE19 RPA1 AHNAK2	1.18e-06	1455	255	29	22863883
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CADM3 ERBB4 NACA PLPPR3 SYNPO CEP170 GSPT2 CPT1C SCN1A CLTA DHX29 SHANK1 AMPH RETREG2 DBNL ATG2B ZDBF2 PPP6R1 SHANK3 C1orf198 P4HB RABEP1 IGHMBP2 PRKAR1B PPP6R2	1.25e-06	1139	255	25	36417873
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	MFAP4 ACAN ABI3BP MMP28 LAMA3 APOB THBS1 VCAN CSPG4	1.43e-06	146	255	9	27068509
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GAPVD1 PSMA5 KDM3B USP19 TASOR2 SURF6 RBM14 TOMM34 AP3D1 FAT4 ZBTB33 PCDHB2 PODXL2 APOB TEX9 PKN1 RPGR SCRIB CLSPN PCDH7	1.44e-06	777	255	20	35844135
Pubmed	HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability.	USP20 HERC2 CLSPN	1.55e-06	4	255	3	25326330
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	MAGEA10 CDH23 GIT2 USP20 NUTM2G HIRA CISH EHBP1L1 MDN1 RBM14 PLA2G6 ATP11A MCF2L APOL2 DOP1B FNIP2 LNX2 APOL1 CERT1 ZNF496 SH2D5 ARPC2 NACC2 MYH14 SNAPC4 NUTM2F	1.81e-06	1242	255	26	30973865
Pubmed	Advancing the understanding of autism disease mechanisms through genetics.	NLGN4X SCN1A NLGN4Y SHANK3	1.92e-06	13	255	4	27050589
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	TPRN NACA BLMH GSPT2 CLTA RBM14 GNL2 CPSF1 NOL7 AP3D1 RIOK1 APOB SERPINH1 ARPC2 SND1 MYH14 PLEKHG3 MDC1 SAFB2 MPHOSPH10 SCRIB RPA1	2.35e-06	949	255	22	36574265
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GAPVD1 NACA KDM3B CEP170 MEX3A GNL2 TOMM34 NCK2 RIOK1 ZBTB33 AKAP3 ZDBF2 PRKRIP1 TEX9 PAIP1 CLMN N4BP2 MDC1 CLSPN	2.40e-06	733	255	19	34672954
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GAPVD1 ZC3H15 PSMA5 NACA USP19 BLMH MDN1 CLTA RBM14 GNL2 CPSF1 NOL7 DHX29 RIOK1 RBBP5 DBNL APOB SERPINH1 ZNF768 LAP3 ARPC2 SND1 MYH14 P4HB MDC1 SAFB2 RPA1 NNT	2.41e-06	1425	255	28	30948266
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	NACA CEP170 EHBP1L1 GSPT2 CD2BP2 SURF6 PRRC2A SERPINH1 SND1 P4HB RABEP1 RPA1 AHNAK2	3.03e-06	360	255	13	33111431
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	ZC3H15 NACA CEP170 PHLPP1 AP3D1 ZBTB33 ATG2B ZDBF2 SND1 SCRIB AHNAK2	3.41e-06	256	255	11	33397691
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	GAPVD1 COBL NHS OFD1 ATG2B ZDBF2 PPP6R1 RABEP1 PRKAR1B SCRIB	3.70e-06	209	255	10	36779422
Pubmed	Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.	CLNS1A SERPINH1 PKN1	3.85e-06	5	255	3	9533029
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ERBB4 APOBR TASOR2 ZNF469 ASAP2 GSPT2 TULP4 SCN1A PRUNE2 CUX2 TEX14 PAIP1 MDC1 CLSPN	4.17e-06	430	255	14	35044719
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	PSMA5 NACA GIT2 CEP170 ASAP2 CD2BP2 SURF6 CLTA CPSF1 COBL NOL7 MCF2L PRRC2A ZBTB33 RBBP5 DBNL SERPINH1 ZNF768 P4HB PLEKHG3 SCRIB	4.76e-06	916	255	21	32203420
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	FREM1 LAMA3 GRIP1 CSPG4	4.79e-06	16	255	4	16880404
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	ZSWIM8 GAPVD1 RPS6KB1 E2F7 USP19 SLIT2 MFAP4 SSH3 KIFC3 MCF2L DHX29 PRRC2A DBNL MSH5 PRKRIP1 ATP13A2 ATF2 C1orf198 P4HB RPGR MYB	5.52e-06	925	255	21	28986522
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	TSR2 KDM3B USP20 USP19 BLMH NAE1 CD2BP2 CLNS1A CLTA GNL2 PHLPP1 HERC2 PRRC2A ZBTB33 PPP6R1 CERT1 PAIP1 SND1 SCRIB CDC25A PPP6R2 ZMYM4	5.83e-06	1005	255	22	19615732
Pubmed	Frem3, a member of the 12 CSPG repeats-containing extracellular matrix protein family, is a basement membrane protein with tissue distribution patterns distinct from those of Fras1, Frem2, and QBRICK/Frem1.	FREM1 FREM3 GRIP1	7.67e-06	6	255	3	17462874
Pubmed	A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1.	FREM1 FREM3 GRIP1 CSPG4	7.97e-06	18	255	4	14730302
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CEP104 EML6 SYNPO TASOR2 MDN1 GSPT2 SCN4A ATP11A ULK1 MCF2L AP3D1 PLXNA3 CUX2 ABI3BP DBNL APOB TEX14 ARPC2 NFE2L3 MYPOP SND1 MYH14 P4HB N4BP2 CSPG4 SAFB2 MPHOSPH10	8.83e-06	1442	255	27	35575683
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RPS6KB1 SYNPO GIT2 HIRA CEP170 MDN1 HERC2 PRRC2A SHANK1 NSD1 PPP6R1 SHANK3 ARPC2 RABEP1 N4BP2 SAFB2 PRKAR1B PKN1 SCRIB RPA1 PPP6R2	1.01e-05	963	255	21	28671696
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	CEP104 SSPOP PHLPP1 ADAMTSL1 PLEKHG3 VPS13B MAST3	1.30e-05	105	255	7	9628581
Pubmed	Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.	SCN1A PCDH19 SCN2A	1.33e-05	7	255	3	25818041
Pubmed	Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells.	SHANK1 SHANK3 GRIP1	1.33e-05	7	255	3	15207857
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	NACA CEP170 PRRC2A OFD1 ATG2B NSD1 PPP6R1 PAIP1 SCRIB CLSPN	1.34e-05	242	255	10	34011540
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GAPVD1 KDM3B CEP170 PRRC2A DPYSL3 ZBTB33 DBNL ATG2B NSD1 KMT2D SND1 RABEP1 MDC1 SCRIB ZMYM4	1.53e-05	549	255	15	38280479
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	NACA CLNS1A COBL FAT4 DPYSL3 AMPH SAFB2 PKN1 SCRIB PPP6R2	1.54e-05	246	255	10	15345747
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	ERBB4 NACA PLPPR3 TULP4 SCN1A PCDH19 NCK2 SHANK1 SHANK3	1.64e-05	197	255	9	36604605
Pubmed	Characterization of the zinc-induced Shank3 interactome of mouse synaptosome.	NACA CDH23 TASOR2 DPYSL3 AMPH ZNF496 SHANK3	1.65e-05	109	255	7	29111324
Pubmed	Identification of potential nuclear reprogramming and differentiation factors by a novel selection method for cloning chromatin-binding proteins.	MKRN4P SVEP1 NSD1	2.12e-05	8	255	3	15522233
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	GAPVD1 ZC3H15 CEP170 DHX29 EIF2AK3 PRRC2A AP3D1 NCK2 RIOK1 ZBTB33 ATG2B GRIP1 C1orf198 SND1 SCRIB RPA1 PCDH7	2.19e-05	708	255	17	39231216
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	PSMA5 NACA SYNPO HIRA CEP170 MFAP4 JUND MDN1 SURF6 CLTA RBM14 GNL2 COBL DHX29 PRRC2A AP3D1 RBBP5 PPP6R1 SERPINH1 ARPC2 SND1 PLEKHG3 MDC1 SCRIB RPA1 AHNAK2	2.43e-05	1440	255	26	30833792
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GAPVD1 CEP170 GNL2 HERC2 DHX29 EIF2AK3 RBBP5 SERPINH1 SND1 MYH14 MDC1 MPHOSPH10 SCRIB	2.55e-05	440	255	13	34244565
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MRPL12 ZC3H15 PSMA5 NACA KDM3B SYNPO USP19 BLMH CEP170 NAE1 CLTA RBM14 TOMM34 APOL2 DHX29 ZBTB33 SERPINH1 PAIP1 LAP3 SND1 P4HB ZFYVE19 SCRIB NNT AHNAK2	2.85e-05	1367	255	25	32687490
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZC3H15 GIT2 HIRA CEP170 SLIT2 MEX3A CD2BP2 RBM14 DHX29 PRRC2A DBNL ARPC2 SND1 MYH14 MPHOSPH10 NNT AHNAK2	2.90e-05	724	255	17	36232890
Pubmed	International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.	SCN1A SCN2A SCN4A	3.17e-05	9	255	3	16382098
Pubmed	Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.	NLGN4X NLGN4Y SHANK3	3.17e-05	9	255	3	23010509
Pubmed	Expression pattern of neuronal and skeletal muscle voltage-gated Na+ channels in the developing mouse heart.	SCN1A SCN2A SCN4A	3.17e-05	9	255	3	15746173
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ZSWIM8 TPRN E2F7 GIT2 CD2BP2 RBM14 NCK2 ZDBF2 PPP6R1 SERPINH1 RABEP1 N4BP2 CLSPN PPP6R2 ZMYM4	3.38e-05	588	255	15	38580884
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	ZC3H15 CCDC168 MEX3C MEX3A RIOK1 P4HB PALM3 RPA1	3.63e-05	168	255	8	30631154
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	SURF6 GNL2 CPSF1 OFD1 PPP6R1 FMNL3 P4HB	4.01e-05	125	255	7	29467281
Pubmed	FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates.	PSMA5 CEP170 MDN1 RBM14 ULK1 HERC2 OFD1 SAFB2 RPA1	4.35e-05	223	255	9	34226595
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MRPL12 ZC3H15 NACA HIRA MDN1 SURF6 GNL2 CRYBG1 NOL7 HERC2 DHX29 PRRC2A RBBP5 DBNL PHRF1 NSD1 SERPINH1 ZNF768 SND1 P4HB PLEKHG3 IGHMBP2 MDC1 PALM3 MPHOSPH10 ZMYM4	4.64e-05	1497	255	26	31527615
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	KDM3B GIT2 ADGRV1 PHLPP1 DOP1B PRUNE2 CUX2 PCNX1 SCRIB	4.66e-05	225	255	9	12168954
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	NACA CEP170 MDN1 CD2BP2 SURF6 RBM14 GNL2 NOL7 HERC2 DHX29 PRRC2A AP3D1 ZNF768 SND1 IGHMBP2 SAFB2 MPHOSPH10	5.20e-05	759	255	17	35915203
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SLC25A25 USP19 PCDH19 MTMR3 COBL ULK1 MCF2L DOP1B FNIP2 PPP6R1 SCRIB VPS13B	5.33e-05	407	255	12	12693553
Pubmed	Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse.	VCAN CSPG4	5.35e-05	2	255	2	17900358
Pubmed	Myb promotes centriole amplification and later steps of the multiciliogenesis program.	FOXJ1 MYB	5.35e-05	2	255	2	24048590
Pubmed	Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.	APOB LPA	5.35e-05	2	255	2	24859635
Pubmed	Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.	VCAN CSPG4	5.35e-05	2	255	2	15609081
Pubmed	Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif.	APOL2 APOL1	5.35e-05	2	255	2	34316015
Pubmed	OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.	APOB LPA	5.35e-05	2	255	2	21404224
Pubmed	Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).	APOB LPA	5.35e-05	2	255	2	26975530
Pubmed	Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice.	SCN1A SCN2A	5.35e-05	2	255	2	10827969
Pubmed	Nizp1, a novel multitype zinc finger protein that interacts with the NSD1 histone lysine methyltransferase through a unique C2HR motif.	NSD1 ZNF496	5.35e-05	2	255	2	15169884
Pubmed	Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.	SCN1A SCN2A	5.35e-05	2	255	2	19694741
Pubmed	Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice.	SHANK1 SHANK3	5.35e-05	2	255	2	33402706
Pubmed	Differential expression of two sodium channel subtypes in human brain.	SCN1A SCN2A	5.35e-05	2	255	2	1317301
Pubmed	Identification and characterization of versican/PG-M aggregates in cartilage.	ACAN VCAN	5.35e-05	2	255	2	16648631
Pubmed	Lipoprotein (a): impact by ethnicity and environmental and medical conditions.	APOB LPA	5.35e-05	2	255	2	26637279
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4X NLGN4Y	5.35e-05	2	255	2	23183221
Pubmed	Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series.	SCN1A SCN2A	5.35e-05	2	255	2	31439038
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4X NLGN4Y	5.35e-05	2	255	2	24855039
Pubmed	Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.	BLMH LAP3	5.35e-05	2	255	2	17513741
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4X NLGN4Y	5.35e-05	2	255	2	37001827
Pubmed	Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation.	ACAN VCAN	5.35e-05	2	255	2	11932252
Pubmed	Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.	APOB LPA	5.35e-05	2	255	2	26515419
Pubmed	Dravet syndrome and SCN1A gene mutation related-epilepsies: cognitive impairment and its determinants.	SCN1A PCDH19	5.35e-05	2	255	2	21504426
Pubmed	Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.	OBSCN PRUNE2	5.35e-05	2	255	2	17360660
Pubmed	Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.	BCL2L1 PLA2G6	5.35e-05	2	255	2	25762722
Pubmed	Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A.	SCN1A SCN2A	5.35e-05	2	255	2	15249644
Pubmed	Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells.	APOB LPA	5.35e-05	2	255	2	9548923
Pubmed	Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.	APOB LPA	5.35e-05	2	255	2	25614280
Pubmed	Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.	SCN1A PCDH19	5.35e-05	2	255	2	33937968
Pubmed	Sleep Duration, Lipid Profile and Insulin Resistance: Potential Role of Lipoprotein(a).	APOB LPA	5.35e-05	2	255	2	32630105
Pubmed	NSD1 PHD domains bind methylated H3K4 and H3K9 using interactions disrupted by point mutations in human sotos syndrome.	NSD1 ZNF496	5.35e-05	2	255	2	21972110
Pubmed	SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.	SCN1A SCN2A	5.35e-05	2	255	2	30693367
Pubmed	Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.	SCN1A SCN2A	5.35e-05	2	255	2	29649454
Pubmed	Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL.	BCL2L1 ATF2	5.35e-05	2	255	2	20507983
Pubmed	The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.	NOL7 THBS1	5.35e-05	2	255	2	23085760
Pubmed	Cordon-bleu is an actin nucleation factor and controls neuronal morphology.	COBL DBNL	5.35e-05	2	255	2	17956734
Interaction	TOP3B interactions	OBSCN KDM3B DGKQ REXO1 HIRA JUND EHBP1L1 MDN1 TULP4 CD2BP2 SURF6 CLTA RBM14 MTMR3 CPSF1 COBL PLA2G6 ULK1 KIFC3 HERC2 MCF2L PRRC2A AP3D1 NCK2 PLXNA3 RIOK1 OFD1 NSD1 APOB PPP6R1 PRKRIP1 ATP13A2 PAIP1 SBNO2 ARPC2 KMT2D SND1 PLA2G4B CSPG4 MDC1 SAFB2 PCNX1 PKN1 SNAPC4 RPA1 AHNAK2	3.28e-09	1470	247	46	int:TOP3B
Interaction	NEK4 interactions	MAGEA10 SYNPO ACAN CLNS1A TAF7L MTMR3 CPSF1 PLA2G6 HERC2 TRIM36 EIF2AK3 SHANK1 FAT4 RIOK1 ATG2B APOB CERT1 THBS1 P4HB MDC1 RPGR ZMYM4	3.18e-06	582	247	22	int:NEK4
Interaction	XAGE1A interactions	ADGRV1 HIRA FAT4 ZBTB33 ZNF496 PCDH7	1.00e-05	41	247	6	int:XAGE1A
Interaction	C2CD4B interactions	ZSWIM8 ADGRV1 SCN4A FAT4 ZNF496 PCDH7	1.52e-05	44	247	6	int:C2CD4B
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN1A SCN2A SCN4A	6.13e-05	9	166	3	1203
GeneFamily	PDZ domain containing	GRID2IP SHANK1 LNX2 SHANK3 GRIP1 SCRIB MAST3 AHNAK2	8.16e-05	152	166	8	1220
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN VCAN	4.97e-04	4	166	2	574
GeneFamily	Apolipoproteins	APOL2 APOB APOL1	8.95e-04	21	166	3	405
GeneFamily	Protein phosphatase 6 regulatory subunits	PPP6R1 PPP6R2	1.23e-03	6	166	2	699
GeneFamily	ADAMTS like	THSD4 ADAMTSL1	1.71e-03	7	166	2	947
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CADM3 NAP1L5 LYSMD2 SSPOP CADM2 MDN1 NLGN4X AJAP1 KIAA1549L TULP4 SCN1A PCDH19 SCN2A MCF2L DOP1B PLXNA3 DPYSL3 RETREG2 LAMA3 CERT1 SHANK3 GRIP1 PIEZO2 N4BP2 VCAN CNTNAP4 PRKAR1B PCDH7 CDH8 AHNAK2	3.35e-07	1106	252	30	M39071
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	CADM3 DGKQ ADGRV1 SLIT2 KIAA1549L TULP4 CPT1C PCDH19 ATP11A MCF2L SHANK1 CUX2 PODXL2 TEX9 SIRT4 NACC2 PKN1 CLSPN PPP6R2 CDH8	3.43e-05	614	246	20	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4	CADM3 DGKQ ADGRV1 USP20 SLIT2 JUND KIAA1549L TULP4 CPT1C PCDH19 ATP11A MCF2L RIC3 SHANK1 CUX2 PODXL2 SIRT4 NACC2 PKN1 PPP6R2 CDH8	5.02e-05	683	246	21	Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5	CADM3 DGKQ USP20 SLIT2 KIAA1549L TULP4 CPT1C PCDH19 ATP11A SHANK1 CUX2 TAPBPL PODXL2 ZDBF2 TEX9 SIRT4 THBS1 NACC2 PKN1 PPP6R2 CDH8	5.57e-05	688	246	21	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5	CADM3 DGKQ USP20 SLIT2 KIAA1549L TULP4 CPT1C PCDH19 ATP11A MCF2L SHANK1 CUX2 TAPBPL PODXL2 SIRT4 THBS1 NACC2 PKN1 PPP6R2 CDH8	8.90e-05	658	246	20	Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2	ADGRV1 SLIT2 JUND KIAA1549L PCDH19 NHS MCF2L SHANK1 DPYSL3 CUX2 GRIP1 CDH8	1.07e-04	279	246	12	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	CADM3 DGKQ ADGRV1 SLIT2 JUND GSPT2 KIAA1549L TULP4 CPT1C PCDH19 PHLPP1 ATP11A MCF2L RIC3 SHANK1 CUX2 PODXL2 ZDBF2 TEX9 SIRT4 NACC2 PKN1 PPP6R2 CDH8	1.19e-04	893	246	24	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500	NAP1L5 CEP170 SLIT2 ZNF469 EHBP1L1 RBM14 COBL FAT4 ADAMTSL1 ZBTB33 ABI3BP CERT1 THBS1 VCAN PCDH7	1.30e-04	422	246	15	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5	CADM3 DGKQ ADGRV1 USP20 SLIT2 GSPT2 KIAA1549L TULP4 CPT1C PCDH19 ATP11A MCF2L RIC3 SHANK1 CUX2 PODXL2 SIRT4 NACC2 PKN1 PPP6R2 CDH8	1.33e-04	732	246	21	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SVEP1 FREM1 SLIT2 MFAP4 PTPRG NHS FAT4 ABI3BP THBS1 PIEZO2 VCAN PCDH7	1.88e-09	198	256	12	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN ADGRV1 SSPOP FREM1 CADM2 SCN2A FAT4 APOB PIEZO2 CNTNAP4	1.20e-07	184	256	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN ADGRV1 SSPOP FREM1 CADM2 SCN2A FAT4 APOB PIEZO2 CNTNAP4	1.20e-07	184	256	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN ADGRV1 SSPOP FREM1 CADM2 SCN2A FAT4 APOB PIEZO2 CNTNAP4	1.20e-07	184	256	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	THSD4 ERBB4 ADGRV1 SCN1A ATP2C2 COBL ATP11A LNX2 LAMA3 MYH14	1.46e-07	188	256	10	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	SVEP1 FREM1 SLIT2 PTPRG DPYSL3 ABI3BP THBS1 PIEZO2 VCAN PCDH7	1.62e-07	190	256	10	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	COVID-19-Heart-CM_4\|Heart / Disease (COVID-19 only), tissue and cell type	ERBB4 CISH COBL ATP11A EIF2AK3 RIC3 FNIP2 TRIM54 GRIP1 THBS1	1.62e-07	190	256	10	3729648a17093b438398b82e32bbccc3af7b8c5d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 FREM1 SLIT2 MFAP4 NHS ABI3BP THBS1 PIEZO2 VCAN PCDH7	1.70e-07	191	256	10	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SVEP1 FREM1 SLIT2 MFAP4 FAT4 DPYSL3 ADAMTSL1 ABI3BP PIEZO2 PCDH7	1.78e-07	192	256	10	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CCDC168 FREM1 IMPG2 TEX14 FREM3 SMIM40 PIEZO2	2.10e-07	73	256	7	cc89c94a3768b02036757dea86989d9284b214b9
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CCDC168 FREM1 IMPG2 TEX14 FREM3 SMIM40 PIEZO2	2.10e-07	73	256	7	6f28d52700bab981c8a3664ba4762f3572f7e788
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CCDC168 FREM1 IMPG2 TEX14 FREM3 SMIM40 PIEZO2	2.10e-07	73	256	7	ae80fcf3544c18fe0318a8311e96f2448f7cb03c
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	SVEP1 SLIT2 PTPRG NHS DPYSL3 ABI3BP THBS1 PIEZO2 VCAN PCDH7	2.26e-07	197	256	10	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SVEP1 FREM1 SLIT2 MFAP4 PTPRG FAT4 ABI3BP PIEZO2 VCAN PCDH7	2.26e-07	197	256	10	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	SVEP1 SLIT2 PTPRG DPYSL3 ABI3BP SERPINH1 THBS1 PIEZO2 VCAN PCDH7	2.26e-07	197	256	10	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SVEP1 FREM1 CADM2 SLIT2 MFAP4 FAT4 ABI3BP PIEZO2 VCAN PCDH7	2.26e-07	197	256	10	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDH23 SVEP1 SLIT2 MFAP4 DPYSL3 ABI3BP SERPINH1 THBS1 PIEZO2 VCAN	2.37e-07	198	256	10	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ERBB4 ADGRV1 SCN1A ATP2C2 COBL ATP11A LNX2 LAMA3 MYH14	2.48e-07	199	256	10	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	SLIT2 MFAP4 JUND FAT4 DPYSL3 ADAMTSL1 SERPINH1 THBS1 PIEZO2 PCDH7	2.48e-07	199	256	10	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	SVEP1 FREM1 SLIT2 MFAP4 PTPRG FAT4 DPYSL3 ABI3BP PIEZO2 PCDH7	2.48e-07	199	256	10	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	C1QTNF8 SVEP1 FZD9 ACAN SHANK1 FAT4 DPYSL3 ABI3BP ITGA10 VCAN	2.48e-07	199	256	10	abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OBSCN SLIT2 PTPRG ITGA10 THBS1 PIEZO2 VCAN CNTNAP4 PCDH7	9.04e-07	177	256	9	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ERBB4 SLIT2 ACAN ALOX15B LAMA3 NACC2 MYH14 CNTNAP4	1.17e-06	135	256	8	54b2aaf8d322e01a3ff6099c2422d68ecccf96b4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 SVEP1 NHS ANO4 FAT4 ABI3BP LAMA3 N4BP2 VCAN	1.49e-06	188	256	9	6ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 FREM1 SLIT2 MFAP4 NHS ABI3BP THBS1 PIEZO2 PCDH7	1.56e-06	189	256	9	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 SVEP1 NHS ANO4 FAT4 LAMA3 PODXL2 N4BP2 CNTNAP4	1.70e-06	191	256	9	764c3a8829ae1253a0790744138266e81fc075ec
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SVEP1 FREM1 SLIT2 PTPRG FAT4 DPYSL3 ABI3BP PIEZO2 PCDH7	1.70e-06	191	256	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERBB4 ADGRV1 ATP2C2 COBL ATP11A ADAMTSL1 LNX2 LAMA3 CLIC6	1.70e-06	191	256	9	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ERBB4 ADGRV1 ATP2C2 COBL ATP11A LNX2 LAMA3 CLIC6 MYH14	1.78e-06	192	256	9	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	THSD4 SYNPO CADM2 JUND ACAN SCN1A NHS FAT4 ERICH5	1.78e-06	192	256	9	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	THSD4 ERBB4 ADGRV1 ATP2C2 COBL ATP11A LNX2 LAMA3 MYH14	1.78e-06	192	256	9	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 FREM1 SLIT2 MFAP4 NHS ABI3BP THBS1 PIEZO2 PCDH7	1.78e-06	192	256	9	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	THSD4 ERBB4 EML6 FREM1 ASAP2 SCN2A CRYBG1 GRIP1 PCDH7	1.85e-06	193	256	9	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	SVEP1 FREM1 SLIT2 MFAP4 PTPRG FAT4 ABI3BP PIEZO2 PCDH7	1.85e-06	193	256	9	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERBB4 ADGRV1 ATP2C2 COBL ATP11A ADAMTSL1 LAMA3 CLIC6 MYH14	1.85e-06	193	256	9	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SVEP1 FREM1 SLIT2 MFAP4 PTPRG FAT4 PIEZO2 VCAN PCDH7	1.93e-06	194	256	9	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	SVEP1 SLIT2 MMP11 DPYSL3 ABI3BP THBS1 PIEZO2 VCAN PCDH7	1.93e-06	194	256	9	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 ERBB4 ASAP2 SCN2A COBL CRYBG1 DOP1B GRIP1 PCDH7	1.93e-06	194	256	9	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 EML6 GIT2 FREM1 SCN2A CRYBG1 GRIP1 MYH14 PCDH7	1.93e-06	194	256	9	4579b4a44f7c731553a284843c296866027d7c0e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 ERBB4 ASAP2 SCN2A COBL CRYBG1 DOP1B GRIP1 PCDH7	1.93e-06	194	256	9	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CADM3 SVEP1 SLIT2 MFAP4 FAT4 ADAMTSL1 ABI3BP PIEZO2 VCAN	2.02e-06	195	256	9	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB4 HMX1 NLGN4X ACAN SCN1A SCN2A COBL VCAN CSPG4	2.10e-06	196	256	9	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SVEP1 FREM1 SLIT2 MFAP4 FAT4 ABI3BP PIEZO2 VCAN PCDH7	2.10e-06	196	256	9	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	THSD4 SVEP1 SLIT2 KIAA1549L ACAN DPYSL3 ADAMTSL1 ABI3BP SERPINH1	2.10e-06	196	256	9	57df2a57b35be9851ac0b1e5731baa53052511f0
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SVEP1 FREM1 SLIT2 MFAP4 PTPRG ANO4 PIEZO2 VCAN PCDH7	2.10e-06	196	256	9	22538376a95fe3afe8639a216a5497087aa94110
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB4 HMX1 NLGN4X ACAN SCN1A SCN2A COBL VCAN CSPG4	2.10e-06	196	256	9	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	Tracheal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	REXO1 MEX3A BEND6 PCDH19 ABI3BP AKAP3 THBS1 CLSPN AHNAK2	2.19e-06	197	256	9	e91572edbe48d40269ee2cf7c858764cff6985ac
ToppCell	Tracheal-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	REXO1 MEX3A BEND6 PCDH19 ABI3BP AKAP3 THBS1 CLSPN AHNAK2	2.19e-06	197	256	9	7e3f78a61089d1200cc6b0fa2034bf2998651694
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COBL PLA2G6 KIFC3 LAMA3 FREM3 GRIP1 MYH14 PLA2G4B PLEKHG3	2.29e-06	198	256	9	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB4 ADGRV1 PTPRG SCN1A ATP2C2 ATP11A ALOX15B FNIP2 GPAM	2.29e-06	198	256	9	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB4 PTPRG SCN1A COBL ANO4 VCAN CSPG4 PCDH7 XKR5	2.29e-06	198	256	9	02d0d8a212e09c0962ab1dae6a885d26d357f66a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SVEP1 FREM1 SLIT2 MFAP4 FAT4 ABI3BP PIEZO2 VCAN PCDH7	2.29e-06	198	256	9	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ERBB4 ADGRV1 ATP2C2 COBL ATP11A LNX2 LAMA3 MYH14	2.38e-06	199	256	9	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 SLIT2 MFAP4 ZNF469 BEND6 CPT1C FAT4 ABI3BP PIEZO2	2.38e-06	199	256	9	21335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ERBB4 ADGRV1 SCN1A ATP2C2 ATP11A LNX2 LAMA3 MYH14	2.38e-06	199	256	9	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SVEP1 FREM1 SLIT2 MFAP4 PTPRG FAT4 PIEZO2 VCAN PCDH7	2.38e-06	199	256	9	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 FREM1 SLIT2 PTPRG DPYSL3 ABI3BP PIEZO2 VCAN PCDH7	2.48e-06	200	256	9	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 NLGN4X PTPRG PRUNE2 FAT4 ABI3BP ITGA10 FMNL3 VCAN	2.48e-06	200	256	9	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ERBB4 ADGRV1 ATP2C2 COBL MCF2L DOP1B GRIP1 CLMN	2.48e-06	200	256	9	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADGRV1 COBL PLA2G6 ATP11A KIFC3 LAMA3 MYH14 PLA2G4B PALM3	2.48e-06	200	256	9	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 FREM1 SLIT2 DPYSL3 ABI3BP THBS1 PIEZO2 VCAN PCDH7	2.48e-06	200	256	9	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 FREM1 SLIT2 PTPRG ACAN FAT4 ABI3BP PIEZO2 VCAN	2.48e-06	200	256	9	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 FREM1 SLIT2 FAT4 DPYSL3 ABI3BP THBS1 PIEZO2 VCAN	2.48e-06	200	256	9	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 FREM1 SLIT2 DPYSL3 ABI3BP THBS1 PIEZO2 VCAN PCDH7	2.48e-06	200	256	9	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|Lung / Manually curated celltypes from each tissue	SURF6 MCF2L RIC3 ZDBF2 MSH5 KIAA1586 MYPOP PRKAR1B	2.71e-06	151	256	8	9bfb807e1180b31fa9a2c500ce993de9707c070f
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 SVEP1 FREM1 CADM2 KIAA1549L PTPRG GRIP1 CNTNAP4	4.17e-06	160	256	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 SVEP1 FREM1 CADM2 KIAA1549L PTPRG GRIP1 CNTNAP4	4.17e-06	160	256	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM3 APOBR CADM2 NLGN4X SH3TC2 C2orf81 C1orf198 CSPG4	4.37e-06	161	256	8	7d1bc73f4c82465b3f489d6737048b0cd54f22cf
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM3 APOBR CADM2 NLGN4X SH3TC2 C2orf81 C1orf198 CSPG4	4.37e-06	161	256	8	410eef62c83c704cbfc5a1b643c4db11bbdcd81f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM3 APOBR CADM2 NLGN4X SH3TC2 C2orf81 C1orf198 CSPG4	4.37e-06	161	256	8	71022485da6754a2b57b4c3e758e3de4c95cc292
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM3 APOBR CADM2 NLGN4X SH3TC2 C2orf81 C1orf198 CSPG4	4.37e-06	161	256	8	59ae8a7c9a04ecaa335b8064852a5a91a21780bd
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	THSD4 C1QTNF8 CADM2 FZD9 CPNE6 ACAN SCN1A NHS	8.06e-06	175	256	8	a84965d28438a4228d841b357c2cd75cf4b59a63
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	THSD4 ADGRV1 COBL ATP11A LNX2 LAMA3 MYH14 CTSE	9.51e-06	179	256	8	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 SVEP1 PCDH19 FAT4 ABI3BP LAMA3 N4BP2 VCAN	9.51e-06	179	256	8	01302505816f272243659e20d751b61a198a2fc0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 FSCB FREM1 ASAP2 SCN2A CRYBG1 GRIP1 PCDH7	9.90e-06	180	256	8	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MFAP4 PCDH19 SHANK1 FAT4 DPYSL3 VCAN PCDH7 XKR5	9.90e-06	180	256	8	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	facs-Pancreas-Exocrine-18m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 SLIT2 MFAP4 DPYSL3 ADAMTSL1 ABI3BP VCAN PCDH7	1.03e-05	181	256	8	269b39ac65790061d54eab47a8eeb024403f0348
ToppCell	facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 SLIT2 MFAP4 DPYSL3 ADAMTSL1 ABI3BP VCAN PCDH7	1.03e-05	181	256	8	c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM2 MEX3A PCDH19 SCN2A FOXJ1 LURAP1 CUX2 DBNL	1.03e-05	181	256	8	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 SLIT2 MFAP4 DPYSL3 ADAMTSL1 ABI3BP VCAN PCDH7	1.03e-05	181	256	8	cd4f744b6b64ba6c22ec07afd1d3058a2546909d
ToppCell	Hippocampus-Neuronal-Inhibitory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ERBB4 NAP1L5 SCN1A NHS ALOX15B CUX2 GRIP1 NACC2	1.07e-05	182	256	8	b54ae650c04dfd0759c5f5e752b9bf684dd36516
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFAP4 CPT1C SURF6 SCN2A TOMM34 PRUNE2 NFE2L3 MYPOP	1.12e-05	183	256	8	ad7421623e4c0c5ba02eec56e9bdae43ebb88d90
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FZD9 ACAN PRUNE2 DPYSL3 PCDHB2 PODXL2 VCAN CSPG4	1.16e-05	184	256	8	278a7ed764c326450cb70e69ed2175980eaf5fe0
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SVEP1 FREM1 SLIT2 BEND6 PTPRG FAT4 ABI3BP KIAA1586	1.16e-05	184	256	8	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FZD9 ACAN PRUNE2 DPYSL3 PCDHB2 PODXL2 VCAN CSPG4	1.16e-05	184	256	8	8d86e125257ff1d3af8d90577a8b3f0321eca21c
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 CEACAM21 ATP2C2 ATP11A FOXJ1 LAMA3 CLIC6 MYH14	1.16e-05	184	256	8	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SLC25A25 FREM1 ASAP2 SCN2A CRYBG1 GRIP1 PCDH7	1.26e-05	186	256	8	d65fa6d8e8a195ea10cfde1499d096d6acf7a634
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SLC25A25 FREM1 ASAP2 SCN2A CRYBG1 GRIP1 PCDH7	1.26e-05	186	256	8	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	CDH23 TNFRSF10C SSPOP ALOX15B SH2D5 THBS1 CLMN VCAN	1.26e-05	186	256	8	a16ecf70271894a842925f232009e2623d16947e
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRV1 APOBR JUND SCN2A LAMA3 THBS1 VCAN CNTNAP4	1.26e-05	186	256	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 ASAP2 SCN2A CRYBG1 CLIC6 GRIP1 THBS1 PCDH7	1.26e-05	186	256	8	b3358e0fa6d845c81e94d56c8575f016621d28ff
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B0\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	REXO1 NAE1 DOP1B PLXNA3 RBBP5 FMNL3 RABEP1 IGHMBP2	1.31e-05	187	256	8	816d37a70f7ec382a268fe828b3dfe737a36a4bf
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 ATP11A ADAMTSL1 MMP28 LAMA3 FREM3 C1orf198 MYH14	1.31e-05	187	256	8	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	SLIT2 PTPRG NHS PRUNE2 DPYSL3 THBS1 VCAN PCDH7	1.31e-05	187	256	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 SVEP1 NHS FAT4 ABI3BP LAMA3 N4BP2 VCAN	1.36e-05	188	256	8	c66fccdfe68760b8c3efca77e3c25966dc9a8a5f
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	THSD4 ERBB4 ADGRV1 ATP2C2 COBL LNX2 LAMA3 MYH14	1.36e-05	188	256	8	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 EML6 FREM1 ASAP2 SCN2A CRYBG1 GRIP1 PCDH7	1.41e-05	189	256	8	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SVEP1 FREM1 SLIT2 MFAP4 ABI3BP NLGN4Y PIEZO2 PCDH7	1.41e-05	189	256	8	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ERBB4 ADGRV1 ATP2C2 ADAMTSL1 LAMA3 CLIC6 GRIP1 MYH14	1.41e-05	189	256	8	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERBB4 ADGRV1 SCN1A ATP2C2 ATP11A ALOX15B MMP28 MYH14	1.47e-05	190	256	8	27a1a86620fe9b5ee930d388b32352206485e6d0
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	HIRA SLIT2 EHBP1L1 SSH3 MTMR3 APOL2 DEAF1 PODXL2 SBNO2 SND1 IGHMBP2 SAFB2 PCDH7	3.66e-07	199	252	13	4691_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZSWIM8 CISH EHBP1L1 RBM14 ULK1 DEAF1 LAMA3 SBNO2 THBS1 RPGR SNAPC4 MYB	1.75e-06	193	252	12	5215_DN
Drug	Dimethadione [695-53-4]; Up 200; 31uM; PC3; HT_HG-U133A	CADM3 ERBB4 DGKQ TNFRSF10C SPTBN5 CEACAM21 COBL MMP11 ALOX15B RIC3 PRUNE2 VCAN	2.05e-06	196	252	12	4607_UP
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A	HIRA ATP2C2 COBL MCF2L DOP1B SH3TC2 ATG2B ZNF768 SND1 RABEP1 SNAPC4 PPP6R2	2.16e-06	197	252	12	5785_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A	CEP104 USP20 SSH3 PRRC2A AP3D1 RFNG SND1 IGHMBP2 SNAPC4 PPP6R2 MAST3	1.14e-05	194	252	11	2824_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	EHBP1L1 ATP2C2 PLA2G6 ATP11A DEAF1 ITGA10 PODXL2 THBS1 PCNX1 CDC25A AHNAK2	1.25e-05	196	252	11	5624_DN
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	BCL2L1 HIRA EHBP1L1 ATP2C2 MCF2L LAMA3 PODXL2 SND1 PLEKHG3 PRKAR1B CDC25A	1.31e-05	197	252	11	1473_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	CEP104 ACRV1 NACA GIT2 YIPF2 EHBP1L1 AP3D1 SERPINA7 DEAF1 IGHMBP2 CDC25A	1.45e-05	199	252	11	1527_UP
Disease	Generalized Epilepsy with Febrile Seizures Plus	ADGRV1 SCN1A SCN2A	4.69e-05	9	247	3	C3502809
Disease	body weight	CCDC91 GAPVD1 ERBB4 DIS3L2 E2F7 ADGRV1 APOBR CADM2 TTC19 MEX3C SLIT2 MEX3A PTPRG TULP4 ACAN MTMR3 PLA2G6 EIF2AK3 CUX2 SBNO2 CNTNAP4 SCRIB NUTM2F RPA1 PCDH7	6.39e-05	1261	247	25	EFO_0004338
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN1A SCN2A SCN4A	6.66e-05	10	247	3	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN1A SCN2A SCN4A	6.66e-05	10	247	3	DOID:0080422 (implicated_via_orthology)
Disease	Disorder of eye	CDH23 ADGRV1 FREM1 IMPG2 OFD1 ATP13A2 GRIP1 VCAN RPGR	8.03e-05	212	247	9	C0015397
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN1A SCN2A SCN4A	1.21e-04	12	247	3	DOID:0060170 (implicated_via_orthology)
Disease	cardiovascular disease	GIT2 REXO1 SVEP1 FREM1 MEX3C SPTBN5 MCF2L APOB CERT1 LPA PCNX1 CDC25A MYB	1.40e-04	457	247	13	EFO_0000319
Disease	Infantile Severe Myoclonic Epilepsy	SCN1A PCDH19 SCN2A	1.56e-04	13	247	3	C0751122
Disease	cup-to-disc ratio measurement	THSD4 PLPPR3 EHBP1L1 KIAA1549L PLA2G6 FAT4 DPYSL3 ADAMTSL1 ABI3BP FMNL3 PLEKHG3 VCAN	2.99e-04	430	247	12	EFO_0006939
Disease	autism spectrum disorder (implicated_via_orthology)	NLGN4X SCN1A SCN2A SHANK1 NLGN4Y SHANK3 CNTNAP4	3.06e-04	152	247	7	DOID:0060041 (implicated_via_orthology)
Disease	Fraser syndrome (implicated_via_orthology)	FREM1 GRIP1	4.14e-04	4	247	2	DOID:0090001 (implicated_via_orthology)
Disease	age at first birth measurement	FREM1 CADM2 SCN2A PRRC2A FNIP2 TEX14	5.34e-04	120	247	6	EFO_0009101
Disease	cutaneous melanoma	HLA-DOB ADGRV1 TASOR2 PLA2G6 ATP11A HERC2	5.58e-04	121	247	6	EFO_0000389
Disease	smoking behavior, BMI-adjusted waist circumference	CCDC91 DIS3L2 JUND ACAN NSD1 ATP13A2	5.83e-04	122	247	6	EFO_0004318, EFO_0007789
Disease	brain connectivity measurement	CCDC91 THSD4 ERBB4 ADGRV1 PNMA6F SLIT2 TRIM36 DPYSL3 THBS1 VCAN PCDH7	5.99e-04	400	247	11	EFO_0005210
Disease	BMI-adjusted waist circumference, physical activity measurement	CCDC91 DIS3L2 ACAN NSD1 SERPINH1 ATP13A2	6.08e-04	123	247	6	EFO_0007789, EFO_0008002
Disease	post-operative atrial fibrillation, response to surgery	ADGRV1 C13orf42	6.86e-04	5	247	2	EFO_0009951, EFO_0009952
Disease	anxiety disorder (implicated_via_orthology)	KDM3B SCN1A SCN2A	7.93e-04	22	247	3	DOID:2030 (implicated_via_orthology)
Disease	generalised epilepsy	SCN1A TRIM36 AP3D1 PCDH7	9.46e-04	52	247	4	EFO_0005917
Disease	cortical surface area measurement	CCDC91 THSD4 ADGRV1 SVEP1 FZD9 SLIT2 ZNF469 PRRC2A ANO4 FNIP2 DPYSL3 ADAMTSL1 RBBP5 MSH5 CERT1 ATP13A2 GRIP1 THBS1 SND1 VCAN RP1L1 MDC1 PCDH7	9.93e-04	1345	247	23	EFO_0010736
Disease	nevus count, cutaneous melanoma	ADGRV1 TASOR2 PLA2G6 ATP11A HERC2	1.02e-03	91	247	5	EFO_0000389, EFO_0004632
Disease	Lennox-Gastaut syndrome	SCN1A CUX2	1.02e-03	6	247	2	C0238111
Disease	Orofaciodigital Syndromes	FAM149B1 OFD1	1.02e-03	6	247	2	C0029294
Disease	hearing impairment	TPRN CDH23 BCL2L1 ADGRV1 RPGR	1.42e-03	98	247	5	C1384666
Disease	Seizure, Febrile, Simple	SCN1A SCN2A	1.43e-03	7	247	2	C0149886
Disease	Seizure, Febrile, Complex	SCN1A SCN2A	1.43e-03	7	247	2	C0751057
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	GPAM APOB CERT1 NFE2L3 LPA	1.49e-03	99	247	5	EFO_0004611, EFO_0007878
Disease	triglyceride measurement, alcohol consumption measurement	PLA2G6 GPAM APOB NFE2L3 LPA	1.63e-03	101	247	5	EFO_0004530, EFO_0007878
Disease	body fat distribution	CCDC91 PTPRG ACAN ADAMTSL1 AKNAD1 NSD1 VCAN	1.63e-03	202	247	7	EFO_0004341
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	GPAM APOB CERT1 NFE2L3 LPA	1.70e-03	102	247	5	EFO_0004329, EFO_0004611
Disease	neuroimaging measurement	CCDC91 THSD4 BCL2L1 MFSD4B FZD9 SLIT2 ZNF469 EIF2AK3 FOXJ1 DPYSL3 RBBP5 MSH5 ERICH5 ATP13A2 SH2D5 THBS1 SND1 VCAN PCDH7	1.77e-03	1069	247	19	EFO_0004346
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	GPAM APOB CERT1 NFE2L3 LPA	1.77e-03	103	247	5	EFO_0008595, EFO_0020944
Disease	17-hydroxyprogesterone measurement	PRRC2A MSH5 MDC1	1.80e-03	29	247	3	EFO_0010220
Disease	amino acid measurement	CCDC91 ERBB4 E2F7 SYNPO SLIT2 PTPRG SCN4A COBL HTR3D FAT4 C1orf198 VCAN RP1L1 PKN1	1.85e-03	678	247	14	EFO_0005134
Disease	memory impairment	FAT4 SHANK3	1.89e-03	8	247	2	EFO_0001072
Disease	triglycerides to total lipids in IDL percentage	GPAM APOB CERT1 LPA	1.94e-03	63	247	4	EFO_0022329
Disease	obsolete_red blood cell distribution width	CCDC91 TSR2 CDH23 REXO1 CEP170 EHBP1L1 CRYBG1 PLA2G6 ATP11A GRIN3B APOL2 RBBP5 APOB TEX9 FREM3 PAIP1 ARPC2 CDH24 RP1L1 NUTM2F MAST3 MYB	2.26e-03	1347	247	22	EFO_0005192
Disease	low density lipoprotein cholesterol measurement, physical activity	APOB CERT1 NFE2L3 LPA	2.30e-03	66	247	4	EFO_0003940, EFO_0004611
Disease	breast carcinoma (is_marker_for)	BCL2L1 KMT2D MDC1 CDC25A	2.30e-03	66	247	4	DOID:3459 (is_marker_for)
Disease	Febrile Convulsions	SCN1A SCN2A	2.42e-03	9	247	2	C0009952
Disease	BMI-adjusted waist circumference, forced expiratory volume	DIS3L2 CUX2	2.42e-03	9	247	2	EFO_0004314, EFO_0007789
Disease	cholesterol to total lipids in very small VLDL percentage	GPAM APOB CERT1 LPA	2.43e-03	67	247	4	EFO_0022245
Disease	free cholesterol measurement	GPAM APOB CERT1 LPA PPP6R2	2.66e-03	113	247	5	EFO_0008591
Disease	triglycerides to total lipids in very small VLDL percentage	GPAM APOB CERT1 LPA	2.71e-03	69	247	4	EFO_0022341
Disease	acute lymphoblastic leukemia (is_marker_for)	KDM3B BCL2L1 CSPG4	2.86e-03	34	247	3	DOID:9952 (is_marker_for)
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	APOB LPA MAST3	2.86e-03	34	247	3	EFO_0008317, EFO_0008596, EFO_0020947
Disease	cholesteryl esters to total lipids in very small VLDL percentage	GPAM APOB CERT1 LPA	3.00e-03	71	247	4	EFO_0022259
Disease	Asthma, Occupational	HERC2 CDH17	3.00e-03	10	247	2	C0264423
Disease	Kartagener Syndrome	FOXJ1 OFD1 RPGR	3.11e-03	35	247	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	FOXJ1 OFD1 RPGR	3.11e-03	35	247	3	C4551906
Disease	Polynesian Bronchiectasis	FOXJ1 OFD1 RPGR	3.11e-03	35	247	3	C4317124
Disease	body surface area	DIS3L2 E2F7 CADM2 PTPRG ACAN SCN4A MTMR3 PLA2G6 EIF2AK3 NSD1 ATP13A2 SCRIB RPA1	3.19e-03	643	247	13	EFO_0022196
Disease	cervical cancer (is_marker_for)	ERBB4 BCL2L1 MDC1	3.37e-03	36	247	3	DOID:4362 (is_marker_for)
Disease	peak expiratory flow	CCDC91 THSD4 ASAP2 TULP4 ACAN SCN4A FREM3 ATP13A2 PAIP1 PPP6R2 NNT	3.37e-03	498	247	11	EFO_0009718
Disease	serum non-albumin protein measurement	RPS6KB1 BCL2L1 TNFRSF10C CPT1C MTMR3 PHLPP1 PRRC2A CUX2 LPA	3.57e-03	361	247	9	EFO_0004568
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	GPAM APOB CERT1 NFE2L3 LPA	3.57e-03	121	247	5	EFO_0008595, EFO_0020943
Disease	Microphthalmos	HMX1 KMT2D	3.65e-03	11	247	2	C0026010
Disease	intracranial aneurysm (is_implicated_in)	KMT2D VCAN	4.36e-03	12	247	2	DOID:10941 (is_implicated_in)
Disease	Candidemia	SPTBN5 APOL2	4.36e-03	12	247	2	EFO_1001282
Disease	sphingolipid measurement	PRRC2A MSH5 CNTNAP4	4.56e-03	40	247	3	EFO_0004622
Disease	Nonsyndromic Deafness	TPRN CDH23 ADGRV1 MYH14	4.82e-03	81	247	4	C3711374
Disease	platelet component distribution width	GAPVD1 HLA-DOB SVEP1 CLNS1A PLA2G6 PRRC2A NCK2 PRUNE2 SH3TC2 LNX2 ZNF496 ARPC2 PLEKHG3 MYB	4.82e-03	755	247	14	EFO_0007984
Disease	lean body mass	DIS3L2 ADGRV1 CADM2 ACAN MTMR3 AP3D1 NSD1 GPAM VCAN	4.88e-03	379	247	9	EFO_0004995
Disease	Congenital small ears	HMX1 GRIP1 KMT2D	4.89e-03	41	247	3	C0152423
Disease	epilepsy	SCN1A CUX2 PCDH7	4.89e-03	41	247	3	EFO_0000474
Disease	Epilepsy, Cryptogenic	SCN1A PCDH19 SCN2A CERT1	5.03e-03	82	247	4	C0086237
Disease	Awakening Epilepsy	SCN1A PCDH19 SCN2A CERT1	5.03e-03	82	247	4	C0751111
Disease	Aura	SCN1A PCDH19 SCN2A CERT1	5.03e-03	82	247	4	C0236018
Disease	Neurodegeneration with brain iron accumulation	PLA2G6 ATP13A2	5.12e-03	13	247	2	cv:C2931845
Disease	ascorbic acid 2-sulfate measurement	CD2BP2 DEAF1	5.12e-03	13	247	2	EFO_0800169
Disease	Connective Tissue Diseases	ZNF469 PIEZO2	5.12e-03	13	247	2	C0009782
Disease	basophil percentage of granulocytes	ZNF469 RBBP5 GRIP1 MYB	5.25e-03	83	247	4	EFO_0007995
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB CERT1 LPA	5.59e-03	43	247	3	EFO_0022290
Disease	Varicose veins	ADGRV1 ATP13A2 FMNL3 RP1L1 PRKAR1B XKR5	5.87e-03	193	247	6	HP_0002619
Disease	Pneumoconiosis	CDH23 ACAN	5.94e-03	14	247	2	C0032273
Disease	Bagassosis	CDH23 ACAN	5.94e-03	14	247	2	C0004681
Disease	Kartagener syndrome (implicated_via_orthology)	SLIT2 FOXJ1	5.94e-03	14	247	2	DOID:0050144 (implicated_via_orthology)
Disease	femoral neck bone geometry	CCDC91 NSD1	5.94e-03	14	247	2	EFO_0004511
Disease	gestational age	ERBB4 PNMA6F SLIT2 NFE2L3 PCNX1	6.21e-03	138	247	5	EFO_0005112
Disease	C-reactive protein measurement	CADM3 ZSWIM8 ERBB4 RPS6KB1 CCDC168 MFSD4B SSPOP USP20 FZD9 ZNF469 SCN4A PLA2G6 CUX2 APOB SIRT4 MYPOP LPA RP1L1 SNAPC4	6.47e-03	1206	247	19	EFO_0004458
Disease	tonsillectomy risk measurement	CADM2 AJAP1 CD2BP2 MTMR3 SBNO2 MDC1 PPP6R2	6.52e-03	260	247	7	EFO_0007924
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	NFE2L3 LPA MAST3	6.75e-03	46	247	3	EFO_0008317, EFO_0008596, EFO_0020943
Disease	MMR-related febrile seizures	SCN1A SCN2A	6.82e-03	15	247	2	EFO_0006519
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOB LPA	6.82e-03	15	247	2	EFO_0022328
Disease	response to statin, LDL cholesterol change measurement	APOB LPA	6.82e-03	15	247	2	EFO_0007804, GO_0036273
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	FZD9 PLA2G6 GPAM APOB NFE2L3 LPA	6.95e-03	200	247	6	EFO_0004611, EFO_0020945
Disease	Primary Ciliary Dyskinesia	FOXJ1 OFD1 RPGR	7.16e-03	47	247	3	C4551720
Disease	triiodothyronine measurement	ERBB4 SERPINA7	7.75e-03	16	247	2	EFO_0008392
Disease	Early infantile epileptic encephalopathy with suppression bursts	SCN1A SCN2A	7.75e-03	16	247	2	C0393706
Disease	response to haloperidol	AJAP1 CNTNAP4	7.75e-03	16	247	2	GO_1905119
Disease	triglyceride measurement, phospholipid measurement	FZD9 PLA2G6 GPAM APOB LPA	7.84e-03	146	247	5	EFO_0004530, EFO_0004639
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	DGKQ FZD9 PLA2G6 GPAM APOB LPA	7.98e-03	206	247	6	EFO_0004612, EFO_0020947
Disease	cholesterol in small LDL measurement	APOB CERT1 LPA	8.04e-03	49	247	3	EFO_0022227
Disease	cholesteryl esters to total lipids in small VLDL percentage	APOB NFE2L3 LPA	8.04e-03	49	247	3	EFO_0022256
Disease	Takayasu arteritis	HLA-DOB SVEP1 PRRC2A MSH5 SNAPC4	8.29e-03	148	247	5	EFO_1001857
Disease	photoreceptor cell layer thickness measurement	CEP104 MTMR3 COBL IMPG2 RP1L1	8.29e-03	148	247	5	EFO_0803370

Protein segments in the cluster

Peptide	Gene	Start	Entry
NGAVLIADESDPAES	PTPRG	1426	P23470
PAAVSAAAEFENAES	CEP170	1546	Q5SW79
APVAQGATAEIFDDS	ERBB4	1091	Q15303
QGPEATVEEAEAAAF	AKAP2	601	Q9Y2D5
TVEEAEAAAFGSEKP	AKAP2	606	Q9Y2D5
NGFVAAAELPRDEAD	APOL2	36	Q9BQE5
QTLGFDPLSEEAVEQ	CCDC88B	121	A6NC98
FTEDGADEFTLIPDS	VCAN	846	P13611
SLFPEESSGEIAIDQ	VCAN	1541	P13611
FQPEFSSGAEEALVD	VCAN	2761	P13611
EDDIPFVATRQGESS	CSPG4	981	Q6UVK1
AGAPEDASQEEESVL	C6orf120	161	Q7Z4R8
TVEDAEALPAAAGEQ	EIF2AK3	71	Q9NZJ5
LFIASAPFEVAEGEN	CEACAM21	36	Q3KPI0
NKPEAVEVTFADFDG	ARPC2	26	O15144
DNFTAIPEGTNGVEE	DPYSL3	346	Q14195
NEDDEDGIFFLNPIT	FAT4	1881	Q6V0I7
SISIFVNEDGIPETD	ADGRV1	1071	Q8WXG9
TGDEEALESNTFPGV	AJAP1	186	Q9UKB5
FNGDAAPSESFVVLD	ANKRD13C	281	Q8N6S4
EASLPNEDVDFDVAT	C13orf42	176	A0A1B0GVH6
LALPDFSGEEEVSAT	CNTNAP4	381	Q9C0A0
DPFSVLLSVDEADAV	DGKQ	696	P52824
QFSDVEENRTEAPEG	BCL2L1	26	Q07817
EVGLFNELASPFENE	ATF2	81	P15336
LDSDLSDGPVTVQEF	GIT2	416	Q14161
AFLEEVAEGTPAQTE	CISH	41	Q9NSE2
AEERENPALVGSETA	C1orf232	26	A0A0U1RR37
DGPKSDVDFSEILNA	ANO4	36	Q32M45
DDAPDADTAIINAEG	CADM3	371	Q8N126
LSDDALPEGFSQEFE	DHX29	166	Q7Z478
DGSLSPQAEAIEVAA	CLIC6	301	Q96NY7
PGAEEEQLDTAEIAF	CUX2	546	O14529
SPDVIVEAQFDGSDS	DIS3L2	161	Q8IYB7
DNDPLVFGVSGEEAS	CDH23	61	Q9H251
GEFFSLENPSDAEAL	ACRV1	41	P26436
DLLVDESSFTGEAEP	ATP2C2	211	O75185
ESADAPLEVTEGFIQ	ATG2B	61	Q96BY7
GNAFLPGESSSEDEE	BEND6	46	Q5SZJ8
SLDEASGFNIPAEQA	ZFYVE19	376	Q96K21
GDVVLVVPSDSEADQ	AMPH	646	P49418
PVAEEVSALFAGELN	AP3D1	591	O14617
VFDAEDGATSPRNDT	CPNE6	91	O95741
GANSNPFDDEEEAVT	MKRN4P	461	Q13434
GNVDGADTTPEELAA	RBM14	6	Q96PK6
SESDNSVLEIPDAFD	NSD1	656	Q96L73
LDVGSKVSFFQPDDE	CRYZL1	71	O95825
PLVGADSVSENFDTA	RABEP1	441	Q15276
ARQQTFIFTDGDDPE	RFNG	86	Q9Y644
PSSNEEIRLVDDAFG	INTS4	271	Q96HW7
VEGSSPDSDLEFVAN	OFD1	616	O75665
EAAASIEGEDVPQGS	PALM3	311	A6NDB9
LIAVFSVSDPDSGDN	PCDHB2	366	Q9Y5E7
EGPNSLINEEEFFDA	CERT1	311	Q9Y5P4
EDDVPQFTSAGENFD	LAP3	46	P28838
DADISDVAFLVVGDP	DPH5	71	Q9H2P9
AAQIELEISEAASPG	PCDH19	131	Q8TAB3
GVEFEAPQEASEEAT	PODXL2	276	Q9NZ53
EQTDITDLFGADLPV	MDN1	1781	Q9NU22
QFSGDDLVPVEVSDL	GNL2	541	Q13823
EGAQAPLAVEEDASS	MAGEA10	26	P43363
PFAFNLNSDTDVEEG	MDC1	211	Q14676
AQPFGFIDSDTDAEE	MDC1	321	Q14676
NSFSQEEEPVVAGED	LYSMD2	141	Q8IV50
GQIEFDISEPEVAAT	LAMA3	1176	Q16787
LEEVDEAAAESPSFL	NCK2	166	O43639
AAATAVDEESPFLVA	HDGFL1	186	Q5TGJ6
VDEESPFLVAVENGS	HDGFL1	191	Q5TGJ6
NVTDGSTEFEFIIPE	ZBTB33	656	Q86T24
PDVAAAVAAAEDGTE	NUDT17	216	P0C025
LAATEASAEEAPAEV	FSCB	596	Q5H9T9
EEEDLAAVPFLASDN	HERC2	2916	O95714
VADNPDELTFSEGDV	ASAP2	956	O43150
VDTEGPAFLSDVEEN	DOP1B	2181	Q9Y3R5
STDVLGSDFDPNIDE	GAPVD1	656	Q14C86
PKVAASEEQEFAEGF	JUND	126	P17535
LDNPAFEESAGADTT	LNX2	206	Q8N448
GESVTEPGQTFVDAE	CTSE	166	P14091
AQELEEGAAVSEEPS	ADAMTSL1	511	Q8N6G6
EAFDITALQNPDGAA	CDH24	696	Q86UP0
DGEDTLFSEPKFAQV	C1orf198	296	Q9H425
ANAAVGEPAFLSEEF	CPSF1	476	Q10570
LSDDTETDFVAPGEN	GSPT2	476	Q8IYD1
GVASDEEAEEAQPGS	MYH14	1966	Q7Z406
QVAFPEGEEQDAVSG	PCNX1	756	Q96RV3
IVSGLLEEDPDFSAQ	PNMA6F	306	A0A0J9YX94
FEAAAENEAVLLPSG	PLXNA3	576	P51805
ENEDDIQFVSEGPSR	KIAA1586	26	Q9HCI6
SSVFELQVADTPDGE	PCDH7	241	O60245
IDVSQLFDEPDSDSG	NFE2L3	406	Q9Y4A8
TDPDTAADDLEFVLV	FREM1	1051	Q5H8C1
TEEASELAEVPAAAG	HMX1	176	Q9NP08
SVKPSDVGNLDDFAE	EHBP1L1	176	Q8N3D4
VLAADAGPVSEEEVS	PHRF1	236	Q9P1Y6
SGAVPQDLAIFVEFD	KDM3B	56	Q7LBC6
PEAFSQEFGDQDVDL	KDM3B	1431	Q7LBC6
GVFDIDLDQPEDAGS	RPS6KB1	26	P23443
SFLDTVAPSELDEQG	LURAP1	146	Q96LR2
VTFALPDDAETEDTG	MPHOSPH10	331	O00566
LFGSFDPDIQETSNE	LRRC14B	476	A6NHZ5
AETNRTPFDLAEGES	MT-ND1	191	P03886
PASDEEEGAVLFDNS	KIAA1549L	1331	Q6ZVL6
SDESGIVAEFQENGP	MYB	506	P10242
AEAIDDIPFGITSNS	P4HB	176	P07237
FDQDLVTGDDPVLSV	PLA2G4B	81	P0C869
EDPAVLAENAGFSAD	RIC3	311	Q7Z5B4
VSNLALQFGEEDADP	PSMA5	116	P28066
SDADSEALFGVPNDK	MFSD4B	166	Q5TF39
EQPGSFETEIEQFAE	PAIP1	171	Q9H074
APEIGATAFAEVENE	ACAN	421	P16112
FQEGEASAAPEVSGE	ACAN	2156	P16112
PVDDDSDLNVVASFD	RBBP5	146	Q15291
AEASGTEEEEEVPSF	PRKRIP1	166	Q9H875
DEAPEELTFASAQAE	NOL7	61	Q9UMY1
LTQDSDEEPFVGELS	PASD1	196	Q8IV76
DEEPFVGELSSSQGQ	PASD1	201	Q8IV76
VEPAAAAAAAAISDD	PASD1	226	Q8IV76
TPELTVADVAEEGNF	OBSCN	571	Q5VST9
VSDEELFLSADEGPA	OBSCN	5026	Q5VST9
NEDGVTPNDFDFSVS	NLGN4Y	386	Q8NFZ3
PTVQFDFTGIDDLEN	RPA1	296	P27694
LASEDVEGQEAATLP	CD2BP2	66	O95400
SDGAEVELSAPVLQE	CPT1C	16	Q8TCG5
QGEAAAELAEFAPLV	FZD9	66	O00144
SSEVQIPDFDVDLGT	APOB	1061	P04114
EEEPAADSAFGTQVL	ATP13A2	586	Q9NQ11
VAINIIGDPADFSDE	CEP104	146	O60308
DTTPTVAGQFEDADV	CLNS1A	221	P54105
VVEEGLVPFASDSDS	GRID2IP	351	A4D2P6
GTDSPEDFVIQAKAD	HLA-DOB	26	P13765
IGPVDFSSSDEELVD	E2F7	366	Q96AV8
IALVDDSEDPGANVS	CCDC91	116	Q7Z6B0
PDEAAAAAAFAEVTT	DEAF1	86	O75398
GPSLEASEAADVAQD	FNIP2	746	Q9P278
PNQISGTVFSELDDE	FMNL3	581	Q8IVF7
TDAIPVTFIGEVSDD	COBL	536	O75128
EVSDDPVDSGLFSNR	COBL	546	O75128
GAEDAPDADTAIINA	CADM2	406	Q8N3J6
PSVEQAADSLDFDET	FOXJ1	361	Q92949
EENTSDLEGPVAAGD	AKNAD1	191	Q5T1N1
GFVAAAELPRNEADE	APOL1	96	O14791
LEAFFEQALTEETPG	LPA	1036	P08519
SAFVDTAQRKEPEDG	BLMH	116	Q13867
VPFDTELVNLDGAFD	C1QTNF8	136	P60827
SGIEAIATPSDIDND	LYG2	181	Q86SG7
FGTELAETELPNDVQ	MCF2L	251	O15068
FGDTPEELFGQVVSD	MAST3	581	O60307
QDGFADVAVGAPLED	ITGA10	561	O75578
TVADALEPVQFEDGE	PRKAR1B	266	P31321
FLARDEGESAVAEDP	C2orf81	101	A6NN90
SFQLSVEEAPADDAD	C2orf81	226	A6NN90
EEAVRSVAFSPDGSQ	EML6	366	Q6ZMW3
DTEAFDIATLQNPDG	CDH8	676	P55286
EEEEVQENSPATFLG	CCDC168	2346	Q8NDH2
DDAVFDDEVAPNAAS	CRYBG1	36	Q9Y4K1
SVAFLDFSQDELGDP	HIRA	351	P54198
AINGIPTEDSTFEEA	GRIP1	526	Q9Y3R0
EIEFDVAESVIPSSG	GRIP1	556	Q9Y3R0
ESPEILEGSQFVETA	ERICH5	226	Q6P6B1
SAPGSLIFEATDDDQ	CDH17	681	Q12864
NEDGVTPNDFDFSVS	NLGN4X	386	Q8N0W4
DDTEISFDPENLITG	DBNL	386	Q9UJU6
NIDADEDSPSAALFE	PPP6R2	606	O75170
PVTATLSDEDDGFVD	CDC25A	206	P30304
FGDEVTSIPDSESNL	MTMR3	1071	Q13615
GFASDDESNVAVTRP	FAM149B1	296	Q96BN6
PNIEAAAVSLNDGDF	MMP28	371	Q9H239
SFVPAEEAEIGAVDA	MSH5	616	O43196
TAGAEEDFQVTLPED	ALOX15B	46	O15296
SEFAAGQEAAREVPD	NUTM2F	526	A1L443
SEFAAGQEAAREVPD	NUTM2G	511	Q5VZR2
GVPSEIDAAFQDADG	MMP11	431	P24347
AVVVAPEADAEAEAA	GRIN3B	941	O60391
DFPDTDLVLVIGAND	NNT	996	Q13423
QPATTIEAFSDEEVG	RPGR	571	Q92834
AAEDVESDPGDLVFN	FREM3	331	P0C091
VVPGQFDDADSSDSE	RIOK1	11	Q9BRS2
SADIAGDEGTQIPAD	TAF7L	46	Q5H9L4
FSDSEDEAATVPGNE	REXO1	286	Q8N1G1
SFFSSGIDVPEINEE	TRIM36	411	Q9NQ86
SPIEEDFEGIQGAFA	TEX14	1106	Q8IWB6
QVPVLDDGSLEDFTD	TAPBPL	66	Q9BX59
LTEPAQSAETIEEAG	PRUNE2	2401	Q8WUY3
FNVATEESSEPLGED	SCN4A	1601	P35499
QDDFLTPAGDVETSI	SSPOP	706	A2VEC9
SEDSQAEAEGVFVSP	NHS	1421	Q6T4R5
PEAGSEQEVFSAVEG	PLEKHG3	511	A1L390
EQEVFSAVEGPSAEE	PLEKHG3	516	A1L390
EEEPFALGAEASNFQ	SYNPO	661	Q8N3V7
EGPEATNAVTFDADD	KIFC3	461	Q9BVG8
EPSQAAAAAEAAAEE	NAP1L5	11	Q96NT1
EAIAEVAAELNPDGS	GPAM	141	Q9HCL2
VGSFPVDDLDTQESV	SH2D5	31	Q6ZV89
DFSISPNAVSAEEDG	MFAP4	146	P55083
SVGSEDLAVDSPAFD	MEX3C	486	Q5U5Q3
SESEAELAGFSPVVD	RETREG2	281	Q8NC44
SREEFPTLQAAGDQD	PRRC2A	166	P48634
AFELDTDGNPFDQDI	SERPINH1	356	P50454
DVDEADVFLAFAQGP	SMIM40	6	Q5STR5
PDGDVFLSEEQVRSF	SIRT4	201	Q9Y6E7
VQEGEPFSEEATLFT	SND1	571	Q7KZF4
DFNSSPESLVDDDVV	SBNO2	666	Q9Y2G9
LSTGQEEEAENFAPI	SH3TC2	456	Q8TF17
ADGLATEPESVFALD	SURF6	101	O75683
VFGAEVDTPNDFGET	PLA2G6	371	O60733
VSNFDEEFTGEAPTL	PKN1	901	Q16512
SVIQFLEAPIGDEDA	SCRIB	446	Q14160
EEFISEVENAFTGLP	IMPG2	271	Q9BZV3
SEQEADVFSALEEPA	OVCA2	76	Q8WZ82
DEPQFSDNSGAELVI	SVEP1	671	Q4LDE5
PSDQGDVDLDVDFAA	SLC6A7	21	Q99884
GAEILFAAPSEEQAE	SPTBN5	3616	Q9NRC6
GAVPAAAAQEAVEED	MRPL12	106	P52815
PIAVGESDFENLNTE	SCN1A	1116	P35498
QPATSGRDANFLEEE	SHANK1	121	Q9Y566
QDETVLLGVDFPDSS	SSH3	141	Q8TE77
DVFIEESVDQTPAGL	HTR3D	121	Q70Z44
QERPDDFTASVSEGI	AKAP3	271	O75969
SAPGESIEALVDVSE	AHNAK2	2661	Q8IVF2
FALDEGIANPTDAFT	ACY1	171	Q03154
GDAVPTVEREAQAAE	APOBR	31	Q0VD83
AEAAPESVGEAETAE	APOBR	956	Q0VD83
LVSIDAAEIADGNPS	CLMN	111	Q96JQ2
AGEEDPAAAFLAQQE	CLTA	26	P09496
EAFVNDIDESSPGTE	CLTA	196	P09496
GADEDSFVILEPETN	CLSPN	511	Q9HAW4
FDEETGEGPLVNTSD	ATP11A	386	P98196
STIFDVGENLTVPDE	SLC25A25	161	Q6KCM7
IDFQPGASGEEEEVA	TRIM54	326	Q9BYV2
FSRPAAAEEEEQQGA	TTC19	66	Q6DKK2
NVFSEDEDDLPVTGA	TULP4	661	Q9NRJ4
LAAEGDAVVFSAPQE	TULP4	811	Q9NRJ4
PDSVEELRAAGNESF	TOMM34	6	Q15785
EFDTVVEDGSLPQVS	TSR2	76	Q969E8
GPLQLEDVDAAFTDT	USP19	136	O94966
IPESGGDNSVFDIFE	THBS1	21	P07996
GIEAEEAPSEQTLSA	ZNF549	71	Q6P9A3
PVQEEEAGRASASAE	RP1L1	1426	Q8IWN7
GSSEEEPELVFAVNL	SHANK3	1271	Q9BYB0
SSVSDVDQEEPRFGA	PLPPR3	641	Q6T4P5
ENDFLAGSPDAAIDS	MEX3A	301	A1L020
DLPTEEDFEALVSAA	IGHMBP2	876	P38935
GTEAAAVPEVELSDQ	SERPINA7	361	P05543
PIAVGESDFENLNTE	SCN2A	1106	Q99250
PEEELTQFSTLDGDV	PIEZO2	1811	Q9H5I5
PEFEAQSSKFQEGAE	ZNF768	161	Q9H5H4
EEFGANATVETPAAE	TNFRSF10C	151	O14798
GSEVSFDSDDPLQSV	ZDBF2	1196	Q9HCK1
DISVVPEGAFNDLSA	SLIT2	836	O94813
ETEVANSSAPDFGED	SAFB2	136	Q14151
AVPIAVADEGESESE	USP20	121	Q9Y2K6
FGEQEESVNAPFDKT	PPP6R1	576	Q9UPN7
DSSFIDVFADEEPSG	ZNF469	861	Q96JG9
NSETPGDEELGFEAA	ZSWIM8	946	A7E2V4
EPESGEQAVAAVEAL	ZNF496	106	Q96IT1
TFIDEVDSEEAPQAA	TPRN	456	Q4KMQ1
AGEESPFSDSVTLEQ	VPS13B	1296	Q7Z7G8
GLSFNEFTDIPEVLE	PHLPP1	766	O60346
DSDDEEPIEGVFTNG	PHLPP1	1546	O60346
EADGSVAFVPGEAQV	SNAPC4	1166	Q5SXM2
GEIEQFEEAPFSNLE	TASOR2	1301	Q5VWN6
AIDAVPVDENLFTGE	ZC3H15	396	Q8WU90
EFEEATNLLADTPDA	YIPF2	11	Q9BWQ6
ENSSAFEGVPKAEAD	XKR5	466	Q6UX68
ESFLAEGPTNEILDV	THSD4	496	Q6ZMP0
TVPASGEELENITDF	ABI3BP	761	Q7Z7G0
LNSDVSGSFVEESPE	NAE1	96	Q13564
QTADDVAIPEDFSDF	TEX9	141	Q8N6V9
TANLEGAVTFEAPDL	ULK1	816	O75385
GIPVVGSDNEDEQDF	ZMYM4	81	Q5VZL5
DVPAEFQDLVDSLSD	VPS54	696	Q9P1Q0
IEQGLEDLVFTDASP	KMT2D	5246	O14686
AQLAAAAEIDEEPVS	NACA	51	Q13765
VDLSAAANPAFDAGE	NACC2	516	Q96BF6
EAQFSEAPVDLDASE	N4BP2	276	Q86UW6
AGPAAEDAFSAEEET	MYPOP	101	Q86VE0